Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
Palisade Bio management will attend the Leerink Partners Therapeutics Forum in Boston on July 14-15 to participate in one-on-one meetings with institutional investors. CEO JD Finley and President & CMO Dr. Mitchell Jones plan to discuss the company's clinical development strategy and progress with its lead asset PALI-2108.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.